Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M02AA15	LOCAGEL	G	Diclofenac sodium (diethylamine) - 10mg/g	10mg/g	Gel	223,078 L.L
D11AX18	LABDIC RELIEF	G	Diclofenac sodium - 1%w/w, Methyl salicylate - 8%w/w, Menthol - 2%w/w		Gel	263,393 L.L
C01AA05	LANOXIN PG	B	Digoxin - 0.05mg/ml	0.05mg/ml	Elixir	307,740 L.L
C01AA05	LANOXIN	B	Digoxin - 0.25mg	0.25mg	Tablet	215,015 L.L
R05CA12	LIBLAB COUGH SYRUP	G	Dried Ivy leaf extract - 35mg/5ml	35mg/5ml	Syrup	237,860 L.L
R05CA12	LIBLAB COUGH SUPPOSITORIES	G	Dried Ivy leaf extract - 80mg	80mg	Suppository	142,447 L.L
N06AX21	LOXYT 30	G	Duloxetine HCl - 30mg	30mg	Capsule, delayed release	716,716 L.L
N06AX21	LOXYT 60	G	Duloxetine HCl - 60mg	60mg	Capsule, delayed release	831,903 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 2,000UI (20mg)/0.2ml	2,000UI (20mg)/0.2ml	Injectable solution	467,657 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 4,000UI (40mg)/0.4ml	4,000UI (40mg)/0.4ml	Injectable solution	886,936 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 6000UI (60mg)/0.6ml	6000UI (60mg)/0.6ml	Injectable solution	1,085,825 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 8000UI (80mg)/0.8ml	8000UI (80mg)/0.8ml	Injectable solution	1,206,771 L.L
C10AB05	LIPANTHYL	B	Fenofibrate - 160mg	160mg	Tablet, film coated, modified release	1,154,238 L.L
C10AB05	LIPAFIB	G	Fenofibrate - 160mg	160mg	Tablet	627,127 L.L
C10AB05	LIPANTHYL 200 M	B	Fenofibrate - 200mg	200mg	Capsule	1,115,364 L.L
G01AF12	LOMEXIN "T"	B	Fenticonazole nitrate - 1,000mg	1,000mg	Ovule	909,037 L.L
G01AF12	LOMEXIN	B	Fenticonazole nitrate - 200mg	200mg	Ovule	810,359 L.L
D01AC12	LOMEXIN	B	Fenticonazole nitrate - 2g/100g	2%	Cream	758,029 L.L
G01AF12	LOMEXIN	B	Fenticonazole nitrate - 600mg	600mg	Ovule	850,727 L.L
C03CA01	LASIMIDE	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	1,300,328 L.L
C03CA01	LASIX	B	Furosemide - 40mg	40mg	Tablet	120,946 L.L
C03CA01	LASIX	B	Furosemide - 500mg	500mg	Tablet	1,454,038 L.L
C10AB04	LOPID	B	Gemfibrozil - 600mg	600mg	Tablet, film coated	498,566 L.L
C10AB04	LOW-LIP	G	Gemfibrozil - 600mg	600mg	Tablet, film coated	298,333 L.L
A10BB09	LOWZID XR	G	Gliclazide - 60mg	60mg	Tablet, extended release	309,724 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.10%	Lipocream	221,734 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.10%	Lipocream	221,734 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.10%	Lotion	201,576 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.10%	Lotion	201,576 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.10%	Cream	215,015 L.L

...